Sign in
CompletedNo phase

Prospective Observational Trial of IAPA

Key facts

Who runs it
Radboud University Medical Center
Where
Belgium, France, and Netherlands12 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
241 people enrolled
Started
10 Mar 2022
Ended
18 May 2026
Type of study
Observational, 2 groups
Treatments tested
  • Identification of biomarkers for IAPA via patient sampling
Record updated
18 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients with a PCR-positive respiratory virus panel (RVP) result for influenza within 96 hours before or 48 hours after ICU admission
  • Patients who require ICU admission for more than 24 hours for severe influenza
  • Patients who have respiratory distress (respiratory rate >= 25x/minute and paO2/fiO2 < 300 with or without bilateral infiltrates) as the main reason for ICU admission
  • Patients who do not have an EORTC host factor
  • Patients who are at least 18 years of age

Who cannot take part

  • Patients with age < 18 years as extensive sampling is required
  • Expected survival on ICU admission ≤ 48h
  • Patients that are being treated actively with antifungal agents for invasive aspergillosis
  • Patients or their legal representatives who did not sign the informed consent form

This trial has no sites in United States.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

A prospective multi-center observational study to assess the incidence of influenza-associated pulmonary aspergillosis (IAPA) in ICU patients and to identify host- and pathogen related risk factors for IAPA in EORTC negative ICU patients with severe influenza.

The 2 groups in the trial

  • IAPA+

    Influenza patients who develop IAPA during ICU admission

    Treatment: Identification of biomarkers for IAPA via patient sampling

  • IAPA-

    Influenza patients admitted to the ICU not developing IAPA

    Treatment: Identification of biomarkers for IAPA via patient sampling

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Influenza-associated Pulmonary Aspergillosis (IAPA) in ICU Patients With Severe Influenza: Incidence and Host- and Pathogen Related Risk Factors
Record updated
18 June 2026